Pioneering trial to test multiple new treatments for glioblastoma

A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.

Austocystin D’s anticancer efficacy linked to CYP2J2 enzyme activity

Austocystin D, a natural compound produced by fungi, has been recognized for its cytotoxic effects and anticancer activity in various cell types. It exhibits potent

August 27, 2024

Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services | Psychedelic Invest

VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical

May 21, 2024

Sterigenics moves closer to end of ethylene oxide lawsuit as most claimants accept $408M deal

Dive Brief: Almost all the claimants in a lawsuit against Sterigenics over damage allegedly caused by ethylene oxide (EtO) — used to sterilize reusable medical devices — have

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.